Xeomin vs Botox: Which Lasts Longer?

Wrinkles, the hallmark of aging, are not just a cosmetic concern but a reflection of our skin’s history. Up to 90% of visible skin changes attributed to aging are caused by sun exposure. These lines and creases, most prominent on sun-exposed skin like the face and neck, are among the most common concerns people want to address when seeking facial rejuvenation.

Xeomin and Botox emerge as frontrunners in the cosmetic industry. Both are forms of botulinum toxin type A, approved by the FDA, and have revolutionized the approach to managing facial lines. While they share the same goal of smoothing out wrinkles, their formulations differ, with Xeomin being the ‘naked injectable’ due to its lack of additives.

This article will delve into the variations of Xeomin vs Botox. We’ll explore their effectiveness, duration of results, and, ultimately, which product can last longer.

Key Takeaways

• Xeomin and Botox are famous botulinum toxin type A treatments for various medical and aesthetic indications.
• Clinical studies and real-world evidence suggest that the longevity of results may vary between Xeomin and Botox.
• Factors such as dosage, injection technique, and patient characteristics can influence the duration of effect for both treatments.
• Medical professionals should consider these factors when choosing between Xeomin and Botox and developing treatment plans for their patients.

About: Doctor Medica is your trusted supplier of top-quality dermal fillers, viscosupplements, and a range of medical and aesthetic products for your practice. We offer authentic products from leading brands at the lowest prices. Contact Doctor Medica today!

Understanding Botulinum Toxin: Xeomin vs Botox

Xeomin and Botox both contain botulinum toxin type A, which works by blocking nerve signals that trigger muscle contraction. Xeomin is formulated without accessory complexing proteins, which is why it is sometimes described as a more purified or “naked” form of botulinum toxin. This formulation difference does not change the basic neuromuscular mechanism, but it does distinguish Xeomin from other botulinum toxin products [1].

Botox also reduces muscle activity through botulinum toxin type A, but its formulation includes associated proteins around the active neurotoxin. It has a long clinical history across both aesthetic and medical indications, including the treatment of facial lines and selected neurological or muscular conditions. As with Xeomin, the appropriate use depends on the approved indication, treatment area, and the individual patient’s clinical needs.

For clinics that buy Xeomin online, the choice between Xeomin and Botox often comes down to formulation, approved uses, practitioner familiarity, and how each product fits into an established treatment protocol. Rather than treating one as universally better, clinicians can compare their specific characteristics and select the option that best matches the intended cosmetic or therapeutic goal.

Clinical Studies on Longevity

Clinical trials give us a peek into the lasting periods of Xeomin and Botox. According to Xeomin’s manufacturer, their product takes about one week to show improvement in glabellar frown lines. Its effect can stretch from three to six months.

Exploring the outcomes and discoveries from research on Xeomin and Botox reveals insight into their effectiveness and duration. Below is a summarized presentation of findings from various studies, highlighting crucial aspects that medical professionals should consider.

Patients often share how they feel about their treatments. Their happiness and reported benefits are crucial to knowing if a treatment works well. A study focused on using incobotulinumtoxinA for frown lines showed us just that.

Factors Influencing Duration of Effect

Dosage and injection technique significantly affect the duration of Xeomin and Botox. Doctors decide the dosage based on many factors, like the number of muscles they need to treat. They also consider the best way to inject it to get long-term results [2].

Every patient reacts differently to Xeomin and Botox. Age, skin type, muscle mass, and health significantly affect how long the effects last. Because of these differences, some see results for more than 3-4 months.

Moving from how patient characteristics play a role, we see that the treatment area also dramatically affects how long Xeomin or Botox lasts. Different facial areas react in unique ways.

For example, wrinkles on the forehead may smooth out for more extended periods than crow’s feet around the eyes. This is because each area has its own muscle activity and skin thickness.

Considerations for Medical Professionals

Doctors choosing between Xeomin and Botox must consider how long each lasts. Studies show that both can work for about three to six months, but some patients find Xeomin’s effects last longer [3].

Medical professionals must tailor treatment plans after deciding between Xeomin and Botox based on their longevity. This ensures the effects last as long as possible for each patient.

• Understand Each Patient’s Needs: Start by closely listening to what the patient wants from their treatment. Some may prefer subtle changes, while others might aim for more noticeable results.
• Assess Previous Responses: If a patient has had neurotoxin therapy before, review how they reacted to past treatments. This includes any side effects or how long the effects lasted.
• Choose the Right Product: Considering that Xeomin can last up to six months and Botox for three to four months, pick the one that best aligns with the patient’s goals.
• Optimize Dosage: Adjusting the dose can affect the impact and duration of results. Lower doses mean shorter effect times and less risk of unwanted outcomes.
• Refine Injection Technique: The exact spots where injections are placed can alter how well and for how long they work.
• Consider Patient Characteristics: Age, skin type, muscle mass, and lifestyle factors like sun exposure or smoking can all influence treatment effectiveness and longevity.
• Discuss Maintenance Plans: Schedule follow-up appointments in advance to monitor results over time and plan touch-ups if necessary.
• Manage Expectations: Ensure patients have realistic ideas about what botulinum toxin treatments can do and how long those effects will likely last.
• Offer Comprehensive Care: Include advice on skincare or other procedures that support or extend treatment benefits.
• Record Results and Adjustments: Keeping detailed records helps fine-tune future treatments for each individual, providing better custom care over time.

Conclusion

The longevity of results for Xeomin and Botox may vary based on clinical studies, real-world evidence, and individual factors. Medical professionals should carefully consider these factors when choosing between the two treatments and developing personalized treatment plans for their patients.

By understanding the factors that influence the duration of effect, medical professionals can make informed decisions to optimize the outcomes of Xeomin and Botox treatments.

FAQs

1. Which lasts longer, Xeomin or Botox?

Xeomin and Botox last about the same time, usually around 3 to 6 months.

2. Can I switch between Xeomin and Botox for my treatments?

Yes, you can switch between Xeomin and Botox; many people do.

3. Is there a big price difference between Xeomin and Botox?

The prices of Xeomin and Botox are often similar, but they can vary depending on where you go.

4. Do both Xeomin and Botox work the same way?

Both work by relaxing muscles to smooth out wrinkles but have different formulas.

5. How quickly will I see results from either Xeomin or Botox?

You might start seeing results from either treatment about 1-2 weeks after getting it done.

Citations

[1] Penn Medicine. “The Truth About Wrinkles: 5 Common Wrinkle Myths Debunked.” Penn Medicine Health and Wellness, Mar. 2022, https://www.pennmedicine.org/updates/blogs/health-and-wellness/2022/march/the-truth-about-wrinkles.

[2] Park, J., M. S. Lee, and A. R. Harrison. “Profile of Xeomin® (IncobotulinumtoxinA) for the Treatment of Blepharospasm.” Clinical Ophthalmology, vol. 5, 2011, pp. 725–732. https://doi.org/10.2147/OPTH.S13978.

[3] Witmanowski, H., and K. Błochowiak. “The Whole Truth About Botulinum Toxin: A Review.” Postępy Dermatologii i Alergologii, vol. 37, no. 6, 2020, pp. 853–861. https://doi.org/10.5114/ada.2019.82795.